Skip to main content

health care reform

Research in Review
12/13/2016
JCP Editors
The implementation of health care reform in Massachusetts increased surgical resection rates for colorectal cancer and decreased the likelihood of emergent resection, suggesting that insurance expansion may improve...
The implementation of health care reform in Massachusetts increased surgical resection rates for colorectal cancer and decreased the likelihood of emergent resection, suggesting that insurance expansion may improve...
The...
12/13/2016
Journal of Clinical Pathways
Research in Review
11/04/2016
JCP Editors
The National Comprehensive Cancer Network (NCCN) agreed that ongoing monitoring and research regarding financial conflicts of interest (COIs) at the interface of academia, medicine, and industry is critical,...
The National Comprehensive Cancer Network (NCCN) agreed that ongoing monitoring and research regarding financial conflicts of interest (COIs) at the interface of academia, medicine, and industry is critical,...
The...
11/04/2016
Journal of Clinical Pathways
Clinical Pathways GPS
10/12/2016
Although the topic of health care will continue to be a political one, the continued growth of public health care spending suggests that the government will need to continue its shift toward improving the value of...
Although the topic of health care will continue to be a political one, the continued growth of public health care spending suggests that the government will need to continue its shift toward improving the value of...
...
10/12/2016
Journal of Clinical Pathways
Research in Review
09/01/2016
JCP Editors
Off-label drug use, which is widely practiced in oncology care, accounted for $5 billion in cancer drug costs in 2010. Now a team of researchers is recommending an overhaul of the process that determines which cancer...
Off-label drug use, which is widely practiced in oncology care, accounted for $5 billion in cancer drug costs in 2010. Now a team of researchers is recommending an overhaul of the process that determines which cancer...
...
09/01/2016
Journal of Clinical Pathways
Research in Review
08/20/2016
JCP Editors
Cancer-related, direct-to-consumer advertising (CR-DTCA) has the potential to promote misconceptions about the efficacy and toxic effects of new therapeutics, which could be detrimental to patients and the...
Cancer-related, direct-to-consumer advertising (CR-DTCA) has the potential to promote misconceptions about the efficacy and toxic effects of new therapeutics, which could be detrimental to patients and the...
...
08/20/2016
Journal of Clinical Pathways
Interview
06/20/2016
  According to a recent report, prescription drug costs rose by more than 12% in 2014 and are expected to continue to rise by more than 7% through 2018.1 In addition, a study of the out-of-pocket costs...
  According to a recent report, prescription drug costs rose by more than 12% in 2014 and are expected to continue to rise by more than 7% through 2018.1 In addition, a study of the out-of-pocket costs...
...
06/20/2016
Journal of Clinical Pathways
Research in Review
06/20/2016
JCP Editors
A Bundled Payments for Care Improvement model developed at New York University Langone Medical Center (NYULMC), New York City, NY, was successful at improving institutional efficiency and providing more value...
A Bundled Payments for Care Improvement model developed at New York University Langone Medical Center (NYULMC), New York City, NY, was successful at improving institutional efficiency and providing more value...
...
06/20/2016
Journal of Clinical Pathways
06/06/2016
JCP Editors
At the “MACRA Town Hall: Effects on your Medicare Reimbursement,” session, Blase Polite, MD, MPP, University of Chicago, Illinois described MACRA using three key adjectives: personal, immediate, and certain. First,...
At the “MACRA Town Hall: Effects on your Medicare Reimbursement,” session, Blase Polite, MD, MPP, University of Chicago, Illinois described MACRA using three key adjectives: personal, immediate, and certain. First,...
At the...
06/06/2016
Journal of Clinical Pathways
Counterpoint
05/06/2016
Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...
Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...
...
05/06/2016
Journal of Clinical Pathways
Counterpoint
10/27/2015
Are there ways to make drugs more affordable without reducing the incentive to innovate? Dr. Owens makes two principal claims with which we agree. Any dialogue about the rising cost of cancer drugs must, as the...
Are there ways to make drugs more affordable without reducing the incentive to innovate? Dr. Owens makes two principal claims with which we agree. Any dialogue about the rising cost of cancer drugs must, as the...
Are...
10/27/2015
Journal of Clinical Pathways